JENNIFER DAVIS: Open Payments
NPI 1306123005 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 37 payments from 13 companies in 2025. Trend: 2023 $301 · 2024 $709 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $168 |
| ABBVIE INC. | 11 | $163 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Novo Nordisk Inc | 3 | $53 |
| Sage Therapeutics, LLC | 2 | $49 |
| Exact Sciences Corporation | 2 | $38 |
| Amgen Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
Products named: AIRSUPRA, UBRELVY, ZURZUVAE, VRAYLAR, Cologuard Collection Kit, OTEZLA, FARXIGA, Wegovy.
Industry payments across AK — which companies pay providers there.
